Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
University of Wisconsin, Madison
University of Wisconsin, Madison
SWOG Cancer Research Network
University of Kansas Medical Center
The Methodist Hospital Research Institute
University of Nebraska
Hoffmann-La Roche
Icahn School of Medicine at Mount Sinai
EVIVE Biotechnology
Dana-Farber Cancer Institute
Spectrum Pharmaceuticals, Inc
Spectrum Pharmaceuticals, Inc
Columbia University
Lupin Ltd.
Memorial Sloan Kettering Cancer Center
University of Wisconsin, Madison
Celgene
Eli Lilly and Company
National Cancer Institute (NCI)
EVIVE Biotechnology
Amgen
Stanford University
Sandoz
Sandoz
Memorial Sloan Kettering Cancer Center
Emory University
Sandoz
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center